Prostate Cancer Update (2024): Expert Guidance for APPs Webcast


Based on the documented need from the AUA Advanced Prostate Cancer Global Needs Assessment, the AUA is providing additional education to update APPs on the latest advancements in the management of hormone sensitive prostate cancer (HSPC), including treatment intensification. 

Prostate Cancer Update 2024: Expert Guidance for APPs consists of an on-demand course designed specifically for APPs. This course features a multidisciplinary panel engaging in a lively discussion on this topic. This activity is being released in September 2024 in conjunction with Prostate Cancer Awareness Month.


Acknowledgements

Support provided by independent educational grants from:

  • Astellas
  • Lantheus Medical Imaging
  • Novartis Pharmaceuticals Corporation
  • Pfizer, Inc.

Target Audience

  • APPs

Learning Objectives

At the conclusion of this activity, the learner will:

  1. Interpret the latest guidelines for prostate cancer screening, including risk factors and early detection strategies.
  2. Evaluate recent advancements in diagnostic tools and techniques for prostate cancer, including imaging modalities and biopsy methods.
  3. Recognize appropriate use of biomarker testing as it relates to diagnosis and therapy.
  4. Analyze the latest strategies for managing advanced and metastatic prostate cancer, including systemic therapies and multidisciplinary care approaches.
  5. Identify approaches to address quality of life issues and survivorship care for patients with prostate cancer, including management of side effects and psychosocial support.
Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Non-Physician Participation
Course opens: 
09/27/2024
Course expires: 
09/27/2025
Rating: 
0
NameCompany NameRelationship TypeEnd Date
Donahue, MeredithNo relevant financial relationships to disclose
Moses, Kelvin A.No relevant financial relationships to disclose
Cossis, Kara R.JanssenConsultant or AdvisorCurrent
AstraZenecaConsultant or AdvisorCurrent
TolmarConsultant or AdvisorCurrent
AmgenConsultant or AdvisorCurrent
BayerConsultant or AdvisorCurrent
AstellasConsultant or AdvisorCurrent
PfizerMeeting Participant or Lecturer05/17/2024
AccordMeeting Participant or Lecturer03/16/2024
Guelman, LoriNo relevant financial relationships to disclose

EDUCATION COUNCIL DISCLOSURE

PDF icon Education Council Disclosures_June 2024.pdf

COI REVIEW WORK GROUP DISCLOSURES

PDF icon COI Review Workgroup Disclosures_June 2024.pdf

AUA Office of Education Staff has nothing to disclose.

All relevant financial relationships have been mitigated.

METHOD OF PARTICIPATION: 

Learners will participate in this online educational activity by taking the pretest, viewing the webcast and completing the posttest and evaluation. To claim CME credit for this enduring material, learners must complete the posttest, passing with 80% accuracy and submit the program evaluation.

Estimated time to complete this activity: 1.50 hours

Release Date: September, 2024
Expiration Date: September, 2025

ACCREDITATION: 

The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION: 

The American Urological Association designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

OTHER LEARNERS: 

The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.

EVIDENCE BASED CONTENT: 

It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

AUA DISCLOSURE POLICY: 

All persons in a position to control the content of a CME activity are required to disclose to the AUA, as the ACCME-accredited provider, all financial relationships with any ineligible company (formerly commercial interests) during the previous 24 months. An ineligible company is defined as one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The AUA must determine if the individual’s relationships are relevant to the educational content and mitigate any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners with information so they can make their own judgments.

MITIGATION OF IDENTIFIED CONFLICT OF INTEREST: 

All disclosures will be reviewed by the AUA Conflict of Interest (COI) Review Work Group Chair and/or Vice Chair for identification of relevant financial relationships that result in conflicts of interest. The AUA COI Review Work Group, working with Office of Education staff, will document the mechanism(s) for management and mitigation of the conflict of interest and final approval of the activity will be documented prior to implementation.

OFF-LABEL OR UNAPPROVED USE OF DRUGS OR DEVICES:

The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.


AUA PARTICIPANT INFORMATION & POLICIES


DISCLAIMER:

The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.

REPRODUCTION PERMISSION: 

Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association.

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Non-Physician Participation
Please login or register to take this course.